US Patent Issued to QIAGEN Sciences on Sept. 16 for "Nucleic acid isolation and inhibitor removal from complex samples" (California Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,999, issued on Sept. 16, was assigned to QIAGEN Sciences LLC (Germantown, Md.).

"Nucleic acid isolation and inhibitor removal from complex samples" was invented by Heather Callahan (Escondido, Calif.), Victoria Nieciecki (Vista, Calif.), Emelia Deforce (Oceanside, Calif.) and Eddie W. Adams (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods for isolating nucleic acids from a sample, comprising: (a) contacting a sample, a lysate of the sample, a supernatant of the lysate, or a portion of the sample, the lysate or the supernatant with one or more first agents (e.g., protein precipitating agents) and one ...